Pediatric movement disorders: An update

Current Opinion in Neurology

Volumn 21, Issue 4, 2008, Pages 491-496

  Wolf, David S ^a   Singer, Harvey S ^a,b  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Infantile masturbation; PANDAS; Restless leg syndrome; Stereotypies; Sydenham's chorea

Indexed keywords

IMMUNOGLOBULIN; METHYLPREDNISOLONE; PERGOLIDE; PLACEBO; PRAMIPEXOLE; PREDNISONE;

AUTOIMMUNE DISEASE; CHOREA MINOR; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC ERROR; DYSTONIA; HUMAN; MOTOR DYSFUNCTION; PATHOGENESIS; RESTLESS LEGS SYNDROME; REVIEW; SEIZURE; SELF STIMULATION; STEREOTYPY; STREPTOCOCCUS INFECTION; ADOLESCENT; CHILD; CHOREA; INFANT; NEUROLOGY; NEWBORN; PATHOPHYSIOLOGY; PEDIATRICS; PRESCHOOL CHILD;

ADOLESCENT; AUTOIMMUNE DISEASES; CHILD; CHILD, PRESCHOOL; CHOREA; HUMANS; INFANT; INFANT, NEWBORN; MOVEMENT DISORDERS; NEUROLOGY; PEDIATRICS; RESTLESS LEGS SYNDROME; SELF STIMULATION; STEREOTYPED BEHAVIOR; STREPTOCOCCAL INFECTIONS;

EID: 52049107843     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/wco.0b013e328307bf1c     Document Type: Review

References (55)

1. Temudo T, Oliveira P, Santos M, et al. Stereotypies in Rett syndrome: analysis of 83 patients with and without detected MECP2 mutations. Neurology 2007; 68:1183-1187.
2. MacDonald R, Green G, Mansfield R, et al. Stereotypy in young children with autism and typically developing children. Res Dev Disabil 2007; 28:266-277.
3. Harris KM, Mahone EM, Singer HS. Nonautistic motor stereotypies: clinical features and longitudinal follow-up. Pediatr Neurol 2008; 38:267-272.
4. Miller JM, Singer HS, Bridges DD, et al. Behavioral therapy for treatment of stereotypic movements in nonautistic children. J Child Neurol 2006; 21:119-125.
5. Mendez MF, Shapira JS, Miller BL. Stereotypical movements and frontotemporal dementia. Mov Disord 2005; 20:742-745.
6. Kashihara K, Imamura T. Amantadine may reverse punding in Parkinson's disease: observation in a patient. Mov Disord 2008; 23:129-130.
7. Silveira-Moriyama L, Evans AH, Katzenschlager R, et al. Punding and dyskinesias. Mov Disord 2006; 21:2214-2217.
8. Crochard A, El Hasnaoui A, Pouchain D, et al. Diagnostic indicators of restless legs syndrome in primary care consultations: the DESYR study. Mov Disord 2007; 22:791-797; quiz 907.
9. Picchietti D, Allen RP, Walters AS, et al. Restless legs syndrome: prevalence and impact in children and adolescents - the Peds REST study. Pediatrics 2007; 120:253-266.
10. Picchietti D, Stevens HE. Early manifestations of restless leg syndrome in childhood and adolescence. Sleep Med 2007; 15 Nov [Epub ahead of print].
11. Winkelmann J, Lichtner P, Schormair B, et al. Variants in the neuronal nitric oxide synthase (Nnos, NOS1) gene are associated with restless legs syndrome. Mov Disord 2007; 23:350-358.
12. Lohmann-Hedrich K, Neumann A, Kleensang A, et al. Evidence for linkage of restless legs syndrome to chromosome 9p: are there two distinct loci? Neurology 2008; 70:686-694.
13. Muhle H, Neumann A, Lohmann-Hedrich K, et al. Childhood-onset restless legs syndrome: clinical and genetic features of 22 families. Mov Disord 2008; 31 Mar [Epub ahead of print].
14. WinkelmanJW. Considering the causes of RLS. Eur J Neurol 2006; 13 (Suppl 3):8-14.
15. Konofal E, Cortese S, Marchand M, et al. Impact of restless legs syndrome and iron deficiency on attention-deficit/hyperactivity disorder in children. Sleep Med 2007; 8:711-715.
16. Oner P, Dirik EB, Taner Y, et al. Association between low serum ferritin and restless legs syndrome in patients with attention deficit hyperactivity disorder. Tohoku J Exp Med 2007; 213:269-276.
17. Walters AS, Mandelbaum DE, Lewin DS, et al. Dopaminergic therapy in children with restless legs/periodic limb movements in sleep and ADHD. Dopaminergic Therapy Study Group. Pediatr Neurol 2000; 22:182-186.
18. Mohri I, Kato-Nishimura K, Tachibana N, et al. Restless legs syndrome (RLS): an unrecognized cause for bedtime problems and insomnia in children. Sleep Med 2007; 8:S91.
19. Nechay A, Ross LM, Stephenson JB, et al. Gratification disorder ('infantile masturbation'): a review. Arch Dis Child 2004; 89:225-226.
20. Yang ML, Fullwood E, Goldstein J, et al. Masturbation in infancy and early childhood presenting as a movement disorder: 12 cases and a review of the literature. Pediatrics 2005; 116:1427-1432.
21. Mouton S, Xie-Brustolin J, Mertens P, et al. Chorea induced by globus pallidus externus stimulation in a dystonic patient. Mov Disord 2006; 21:1771-1 773.
22. Cardoso F, Lees AJ. Did Gustav Mahler have Sydenham's chorea? Mov Disord 2006; 21:289-292.
23. Husby G, van de Rijn I, Zabriskie JB, et al. Antibodies reacting with cytoplasm of subthalamic and caudate nuclei neurons in chorea and acute rheumatic fever. J Exp Med 1976; 144:1094-1110.
24. Kirvan CA, Cox CJ, Swedo SE, et al. Tubulin is a neuronal target of auto-antibodies in Sydenham's chorea. J Immunol 2007; 178:741 2-7421.
25. Kirvan CA, Swedo SE, KuraharaD, et al. Streptococcal mimicry and antibody-mediated cell signaling in the pathogenesis of Sydenham's chorea. Autoimmunity 2006; 39:21-29.
26. Demiroren K, Yavuz H,Cam L, et al. Sydenham's chorea: a clinical follow-up of 65 patients. J Child Neurol 2007; 22:550-554.
27. Zomorrodi A, Wald ER. Sydenham's chorea in western Pennsylvania. Pediatrics 2006; 117:e675-e679.
28. Aron AM. Sydenham's chorea: positron emission tomographic (PET) scan studies. J Child Neurol 2005; 20:832-833.
29. Kabakus N, Balci TA, Kurt A, et al. Cerebral blood flow abnormalities in children with Sydenham's chorea: a SPECT study. Indian Pediatr 2006; 43:241-246.
30. Margari L, Ventura P, Portoghese C, et al. Brain magnetic resonance spectroscopy in Sydenham's chorea and ADHD. Pediatr Neurol 2006; 34:467-473.
31. Paz JA, Silva CA, Marques-Dias MJ. Randomized double-blind study with prednisone in Sydenham's chorea. Pediatr Neurol 2006; 34:264-269.
32. Teixeira AL Jr, Cardoso F. Corticosteroids in the treatment of acute Sydenham's chorea. Pediatr Neurol 2006; 34:168-169; author reply 1 69.
33. Garvey MA, Snider LA, Leitman SF, et al. Treatment of Sydenham's chorea with intravenous immunoglobulin, plasma exchange, or prednisone. J Child Neurol 2005; 20:424-429.
34. Tumas V, Caldas CT, Santos AC, et al. Sydenham's chorea: clinical observations from a Brazilian movement disorder clinic. Parkinsonism Relat Disord 2007; 13:276-283.
35. Church AJ, Dale RC, Lees AJ, et al. Tourette's syndrome: a cross sectional study to examine the PANDAS hypothesis. J Neurol Neurosurg Psychiatry 2003; 74:602-607.
36. Edwards MJ, Dale RC, Church AJ, et al. A dystonic syndrome associated with antibasal ganglia antibodies. J Neurol Neurosurg Psychiatry 2004; 75:914-916.
37. DiFazio MP, Morales J, Davis R. Acute myoclonus secondary to group A beta-hemolytic streptococcus infection: a PANDAS variant. J Child Neurol 1998; 13:516-518.
38. Ben-Pazi H, Livne A, Shapira Y, et al. Parkinsonian features after streptococcal pharyngitis. J Pediatr 2003; 143:267-269.
39. Dassan P, Clarke C, Sharp DJ. A case of poststreptococcal opsoclonus-myoclonus syndrome. Mov Disord 2007; 22:1490-1491.
40. Dale RC, Church AJ, Surtees RA, et al. Poststreptococcal autoimmune neuropsychiatric disease presenting as paroxysmal dystonic choreoathetosis. Mov Disord 2002; 17:817-820.
41. Archelos JJ, Hartung HP. Pathogenetic role of autoantibodies in neurological diseases. Trends Neurosci 2000; 23:317-327.
42. Swedo SE, Leonard HL, Garvey M, et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry 1998; 155:264-271.
43. Snider LA, Swedo SE. Poststreptococcal autoimmune disorders of the central nervous system. Curr Opin Neurol 2003; 16:359-365.
44. Kurlan R. The PANDAS hypothesis: losing its bite? Mov Disord 2004; 19:371-374.
45. Kurlan R, Kaplan EL. The pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS) etiology for tics and obsessive-compulsive symptoms: hypothesis or entity? Practical considerations for the clinician. Pediatrics 2004; 113:883-886.
46. Perrin EM, Murphy ML, Casey JR, et al. Does group A beta-hemolytic streptococcal infection increase risk for behavioral and neuropsychiatric symptoms in children? Arch Pediatr Adolesc Med 2004; 158:848-856.
47. Mell LK, Davis RL, Owens D. Association between streptococcal infection and obsessive-compulsive disorder, Tourette's syndrome, and tic disorder. Pediatrics 2005; 116:56-60.
48. Murphy TK, Snider LA, Mutch PJ, et al. Relationship of movements and behaviors to Group A Streptococcus infections in elementary school children. Biol Psychiatry 2007; 61:279-284.
49. The Tourette Syndrome Study Group, Johnson D, Kaplan EL. Streptococcal infection and exacerbations of childhood tics and obsessive-compulsive symptoms: a prospective blinded cohort study. Pediatrics (in press).
50. Pavone P, Bianchini R, Parano E, et al. Antibrain antibodies in PANDAS versus uncomplicated streptococcal infection. Pediatr Neurol 2004; 30:1 07-110.
51. Church AJ, Dale RC, Giovannoni G. Antibasal ganglia antibodies: a possible diagnostic utility in idiopathic movement disorders? Arch Dis Child 2004; 89:611-614.
52. Dale RC, Candler PM, Church AJ, et al. Neuronal surface glycolytic enzymes are autoantigen targets in poststreptococcal autoimmune CNS disease. J Neuroimmunol 2006; 172:187-197.
53. Singer HS, Loiselle CR, Lee O, et al. Antibasal ganglia antibodies in PANDAS. Mov Disord 2004; 19:406-415.
54. Singer HS, Hong JJ, Yoon DY, et al. Serum autoantibodies do not differentiate PANDAS and Tourette syndrome from controls. Neurology 2005; 65:1701-1707.
55. Singer HS, Gause C, Morris C, et al. Serial immune markers do not correlate with clinical exacerbations in PANDAS. Pediatrics 2008 [Epub ahead of print].